Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Meng‐xuan Zuo"'
Autor:
Tian-Qi Zhang, Zhi-Jun Geng, Meng-Xuan Zuo, Ji-Bin Li, Jin-Hua Huang, Zi-Lin Huang, Pei-Hong Wu, Yang-Kui Gu
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 8, Iss 1, Pp 1-7 (2023)
Abstract Hepatic arterial infusion chemotherapy (HAIC) using a combination of oxaliplatin, fluorouracil, and leucovorin (FOLFOX) has shown promise for hepatocellular carcinoma (HCC) patients classified under Barcelona Clinic Liver Cancer (BCLC) stage
Externí odkaz:
https://doaj.org/article/b8acba41e559430f803d5642c0d9caa6
Autor:
Zhi‐mei Huang, Meng‐xuan Zuo, Yang‐kui Gu, Chun‐xiao Lai, Qiu‐xiang Pan, Xiao‐cheng Yi, Tian‐qi Zhang, Jin‐hua Huang
Publikováno v:
Thoracic Cancer, Vol 11, Iss 5, Pp 1233-1238 (2020)
Background Bronchobiliary fistula is a rare, but life‐threatening complication after ablation of hepatocellular carcinoma. Few cases of bronchobiliary fistula have been reported and the treatment is controversial. Methods From 2006 to 2019, a total
Externí odkaz:
https://doaj.org/article/a28fbd7a1b3f47638689115760f34918
Autor:
Wei Zhang, Jie‐Fei Bai, Meng‐Xuan Zuo, Xin‐Xin Cao, Miao Chen, Yan Zhang, Xiao Han, Ding‐Rong Zhong, Dao‐Bin Zhou
Publikováno v:
Cancer Medicine, Vol 5, Iss 11, Pp 3077-3084 (2016)
Abstract The aim of the study was to investigate the relationship between PD‐1 expression on the surface of CD4+ T cells and prognosis of patients with diffuse large B‐cell lymphoma (DLBCL). Sixty patients who were newly diagnosed with DLBCL and
Externí odkaz:
https://doaj.org/article/0cbc7a220bd144de9c0d5b56facd034d
Publikováno v:
Journal of Personalized Medicine; Volume 13; Issue 2; Pages: 246
Background: Combined hepatocellular carcinoma and cholangiocarcinoma (cHCC-CCA) is a rare form of primary liver malignancy. Microvascular invasion (MVI) indicates poor postsurgical prognosis in cHCC-CCA. The objective of this study was to investigate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a558090d1c248dcc77442d143ed1c983
Autor:
Chun xiao Lai, Yang Kui Gu, Zhi Mei Huang, Qiu xiang Pan, Tian Qi Zhang, Meng xuan Zuo, Jinhua Huang, Xiao cheng Yi
Publikováno v:
Thoracic Cancer, Vol 11, Iss 5, Pp 1233-1238 (2020)
Thoracic Cancer
Thoracic Cancer
Background Bronchobiliary fistula is a rare, but life-threatening complication after ablation of hepatocellular carcinoma. Few cases of bronchobiliary fistula have been reported and the treatment is controversial. Methods From 2006 to 2019, a total o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d608bbc14197933f1c6dd53513356eaa
https://doi.org/10.1111/1759-7714.13380
https://doi.org/10.1111/1759-7714.13380
Autor:
Yang-Kui Gu, Tian-Qi Zhang, Meng-Xuan Zuo, Zhi-Jun Geng, Ji-Bin Li, Zi-Lin Huang, Pei-Hong Wu
Publikováno v:
Journal of Clinical Oncology. 40:4106-4106
4106 Background: The combination of anti-angiogenesis and immune checkpoint blockade has been proven to improve clinical outcomes of advanced HCC. We assessed the efficacy and safety of HAIC combined with apatinib and camrelizumab for BCLC stage C HC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22e46114bd6c40840b8d7622c7a5e328
https://doi.org/10.1200/jco.2022.40.16_suppl.4106
https://doi.org/10.1200/jco.2022.40.16_suppl.4106
Autor:
Jinhua Huang, Xue Han, Hao Chen, Yang Kui Gu, Qing qing Cai, Han xia Deng, Shao long Li, Meng xuan Zuo, Minshan Chen
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 145:303-312
Anti-programmed cell death-1 (PD-1)/programmed cell death-ligand 1 (PD-L1) therapy has shown promise in tumor immunotherapy. Our objectives were to measure pre-treatment serum-soluble PD-L1 (sPD-L1) levels and to assess the relationships between sPD-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fc8b846aebf905f1ba873d95e7f52c1
https://doi.org/10.1007/s00432-018-2758-6
https://doi.org/10.1007/s00432-018-2758-6